{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:20:42Z","timestamp":1787235642624,"version":"build-2736575974"},"reference-count":54,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T00:00:00Z","timestamp":1659225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004606","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3D0651"],"award-info":[{"award-number":["CMRPG3D0651"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3E2001"],"award-info":[{"award-number":["CMRPG3E2001"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3L0711"],"award-info":[{"award-number":["CMRPG3L0711"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["107-2314-B-182A-016"],"award-info":[{"award-number":["107-2314-B-182A-016"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["110-2314-B-182A-056"],"award-info":[{"award-number":["110-2314-B-182A-056"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Science and Technology of Taiwan","award":["CMRPG3D0651"],"award-info":[{"award-number":["CMRPG3D0651"]}]},{"name":"Ministry of Science and Technology of Taiwan","award":["CMRPG3E2001"],"award-info":[{"award-number":["CMRPG3E2001"]}]},{"name":"Ministry of Science and Technology of Taiwan","award":["CMRPG3L0711"],"award-info":[{"award-number":["CMRPG3L0711"]}]},{"name":"Ministry of Science and Technology of Taiwan","award":["107-2314-B-182A-016"],"award-info":[{"award-number":["107-2314-B-182A-016"]}]},{"name":"Ministry of Science and Technology of Taiwan","award":["110-2314-B-182A-056"],"award-info":[{"award-number":["110-2314-B-182A-056"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The aberrant activation of the purinergic signaling pathway has been shown to promote cyst growth and fluid secretion in autosomal dominant polycystic kidney disease (ADPKD). Suramin is an anti-parasitic drug that has strong anti-purinergic properties. Whether suramin could have a therapeutic effect on ADPKD has not been fully investigated. We examined the effect of suramin on cyst progression in a Pkd1 microRNAs transgenic mouse model that presented stable Pkd1 knockdown and moderate disease progression. The Pkd1-deficient mice were treated with suramin (60 mg\/kg) by intraperitoneal injection twice a week from postnatal days 35 to 90. Kidney-to-body weight ratios, cyst indices, and blood urea nitrogen (BUN) levels were measured. Cell proliferation and macrophage infiltration were determined by immunohistochemistry. The suramin-treated group had significantly lower renal cyst densities, cell proliferation, and macrophage infiltration compared with saline-treated controls. Suramin significantly inhibited ERK phosphorylation and the expression of Il1b, Il6, Nlrp3, Tgfb, Fn1, P2rx7, and P2ry2 mRNAs in the kidneys. However, BUN levels remained high despite the reduction in cyst growth. Furthermore, plasma cystatin C and neutrophil gelatinase-associated lipocalin (NGAL) levels were significantly higher in the suramin-treated group compared with the control group. Periodic acid-Schiff staining revealed degenerative changes and epithelial cell vacuolation in the non-cystic renal tubules, which indicated phospholipidosis following suramin treatment. These results suggest that suramin may reduce renal cyst growth and inflammation, but the associated tubular cell injuries could limit its therapeutic potential. Other purinergic receptor antagonists with less nephrotoxicity may deserve further investigation for the treatment of ADPKD.<\/jats:p>","DOI":"10.3390\/ijms23158499","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T02:06:42Z","timestamp":1659319602000},"page":"8499","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effects of Suramin on Polycystic Kidney Disease in a Mouse Model of Polycystin-1 Deficiency"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8899-0376","authenticated-orcid":false,"given":"Ming-Yang","family":"Chang","sequence":"first","affiliation":[{"name":"Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan 333, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3527-4151","authenticated-orcid":false,"given":"Shen-Hsing","family":"Hsu","sequence":"additional","affiliation":[{"name":"Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan 333, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9776-8643","authenticated-orcid":false,"given":"Li-Yi","family":"Ma","sequence":"additional","affiliation":[{"name":"Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan 333, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Feng","family":"Chou","sequence":"additional","affiliation":[{"name":"Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan 333, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chieh","family":"Hung","sequence":"additional","affiliation":[{"name":"Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan 333, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1104-889X","authenticated-orcid":false,"given":"Ya-Chung","family":"Tian","sequence":"additional","affiliation":[{"name":"Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan 333, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Wei","family":"Yang","sequence":"additional","affiliation":[{"name":"Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan 333, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","article-title":"Autosomal dominant polycystic kidney disease","volume":"393","author":"Alam","year":"2019","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41588-021-00946-4","article-title":"Renal plasticity revealed through reversal of polycystic kidney disease in mice","volume":"53","author":"Dong","year":"2021","journal-title":"Nat. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Zhou, J.X., Fan, L.X., Li, X., and Calvet, J.P. (2015). TNFalpha signaling regulates cystic epithelial cell proliferation through Akt\/mTOR and ERK\/MAPK\/Cdk2 mediated Id2 signaling. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0131043"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41436-018-0324-x","article-title":"Population data improves variant interpretation in autosomal dominant polycystic kidney disease","volume":"21","author":"Mallawaarachchi","year":"2019","journal-title":"Genet. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"18067","DOI":"10.1073\/pnas.1111966108","article-title":"Signal transducer and activator of transcription-6 (STAT6) inhibition suppresses renal cyst growth in polycystic kidney disease","volume":"108","author":"Olsan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/s41598-019-38566-y","article-title":"Anti-microRNA screen uncovers miR-17 family within miR-17~92 cluster as the primary driver of kidney cyst growth","volume":"9","author":"Yheskel","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_7","first-page":"489","article-title":"Tolvaptan in Later-Stage Polycystic Kidney Disease","volume":"378","author":"Torres","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_8","first-page":"1259","article-title":"Tolvaptan in autosomal dominant polycystic kidney disease","volume":"368","author":"Torres","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2215\/CJN.13291019","article-title":"Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Evidence and Therapeutic Potential","volume":"15","author":"Nowak","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1096\/fj.201902901R","article-title":"Pannexin-1 mediates fluid shear stress-sensitive purinergic signaling and cyst growth in polycystic kidney disease","volume":"34","author":"Verschuren","year":"2020","journal-title":"FASEB J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000082247","article-title":"Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy\/+ rat, a model of autosomal dominant polycystic kidney disease","volume":"178","author":"Turner","year":"2004","journal-title":"Cells Tissues Organs"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbrc.2019.03.177","article-title":"ATP release into ADPKD cysts via pannexin-1\/P2X7 channels decreases ENaC activity","volume":"513","author":"Arkhipov","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00109-010-0715-1","article-title":"Formation of cysts by principal-like MDCK cells depends on the synergy of cAMP- and ATP-mediated fluid secretion","volume":"89","author":"Buchholz","year":"2011","journal-title":"J. Mol. Med. (Berl.)"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"F1649","DOI":"10.1152\/ajprenal.00395.2019","article-title":"Knockout of P2rx7 purinergic receptor attenuates cyst growth in a rat model of ARPKD","volume":"317","author":"Arkhipov","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1681\/ASN.2010070728","article-title":"Inhibition of the P2X7 receptor reduces cystogenesis in PKD","volume":"22","author":"Chang","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s11302-016-9532-5","article-title":"P2Y2R is a direct target of HIF-1alpha and mediates secretion-dependent cyst growth of renal cyst-forming epithelial cells","volume":"12","author":"Kraus","year":"2016","journal-title":"Purinergic Signal."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1016\/j.bmcl.2016.09.051","article-title":"Targeting the HSP60\/10 chaperonin systems of Trypanosoma brucei as a strategy for treating African sleeping sickness","volume":"26","author":"Abdeen","year":"2016","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41564-020-00844-1","article-title":"Structure of trypanosome coat protein VSGsur and function in suramin resistance","volume":"6","author":"Zeelen","year":"2021","journal-title":"Nat. Microbiol."},{"key":"ref_19","first-page":"2239","article-title":"Suramin: A novel antineoplastic agent with multiple potential mechanisms of action","volume":"53","author":"Stein","year":"1993","journal-title":"Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e01168-19","DOI":"10.1128\/AAC.01168-19","article-title":"100 Years of Suramin","volume":"64","author":"Wiedemar","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2013.12.008","article-title":"Suramin inhibits EV71 infection","volume":"103","author":"Wang","year":"2014","journal-title":"Antivir. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1681\/ASN.2016111211","article-title":"Decreased Expression of Connexin 43 Blunts the Progression of Experimental GN","volume":"28","author":"Kavvadas","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF02889967","article-title":"The suramin-treated rat as a model of mucopolysaccharidosis. Variation in the reversibility of biochemical and morphological changes among different organs","volume":"52","author":"Rees","year":"1986","journal-title":"Virchows Archiv. B Cell Pathol. Incl. Mol. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Guo, C., Wu, Z., Lin, W., Xu, H., Chang, T., Dai, Y., and Lin, D. (2021). Suramin Targets the Conserved Ligand-Binding Pocket of Human Raf1 Kinase Inhibitory Protein. Molecules, 26.","DOI":"10.3390\/molecules26041151"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Naviaux, R.K., Zolkipli, Z., Wang, L., Nakayama, T., Naviaux, J.C., Le, T.P., Schuchbauer, M.A., Rogac, M., Tang, Q., and Dugan, L.L. (2013). Antipurinergic therapy corrects the autism-like features in the poly(IC) mouse model. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057380"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1681\/ASN.2010090956","article-title":"Suramin inhibits renal fibrosis in chronic kidney disease","volume":"22","author":"Liu","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/path.2765","article-title":"Progressive renal distortion by multiple cysts in transgenic mice expressing artificial microRNAs against Pkd1","volume":"222","author":"Wang","year":"2010","journal-title":"J. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/mus.23858","article-title":"Suramin attenuates dystrophin-deficient cardiomyopathy in the mdx mouse model of duchenne muscular dystrophy","volume":"48","author":"Pereira","year":"2013","journal-title":"Muscle Nerve"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/mus.21869","article-title":"Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF-beta1 blocker","volume":"43","author":"Taniguti","year":"2011","journal-title":"Muscle Nerve"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/S0024-3205(00)00865-1","article-title":"The effect of suramin on bleomycin-induced lung injury","volume":"67","author":"Lossos","year":"2000","journal-title":"Life Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.antiviral.2016.07.025","article-title":"Suramin treatment reduces chikungunya pathogenesis in mice","volume":"134","author":"Kuo","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_32","first-page":"2654","article-title":"Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator","volume":"54","author":"Takano","year":"1994","journal-title":"Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"F248","DOI":"10.1152\/ajprenal.00433.2015","article-title":"Suramin protects from cisplatin-induced acute kidney injury","volume":"310","author":"Dupre","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Korrapati, M.C., Howell, L.A., Shaner, B.E., Megyesi, J.K., Siskind, L.J., and Schnellmann, R.G. (2013). Suramin: A potential therapy for diabetic nephropathy. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0073655"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Liu, N., He, S., Tolbert, E., Gong, R., Bayliss, G., and Zhuang, S. (2012). Suramin alleviates glomerular injury and inflammation in the remnant kidney. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0036194"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"F944","DOI":"10.1152\/ajprenal.00387.2010","article-title":"Sorafenib inhibits cAMP-dependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cells","volume":"299","author":"Yamaguchi","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3389\/fnmol.2017.00448","article-title":"P2X7 Nucleotide and EGF Receptors Exert Dual Modulation of the Dual-Specificity Phosphatase 6 (MKP-3) in Granule Neurons and Astrocytes, Contributing to Negative Feedback on ERK Signaling","volume":"10","author":"Queipo","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"F15","DOI":"10.1152\/ajprenal.00103.2006","article-title":"Antagonism of endogenous putative P2Y receptors reduces the growth of MDCK-derived cysts cultured in vitro","volume":"292","author":"Turner","year":"2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"102585","DOI":"10.1016\/j.ebiom.2019.11.046","article-title":"Prioritization of novel ADPKD drug candidates from disease-stage specific gene expression profiles","volume":"51","author":"Malas","year":"2020","journal-title":"EBioMedicine"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1124\/jpet.111.181727","article-title":"Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathy","volume":"338","author":"Liu","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-981-13-8871-2_5","article-title":"Polycystic Kidney Disease and Renal Fibrosis","volume":"1165","author":"Xue","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1681\/ASN.2018050518","article-title":"Mcp1 Promotes Macrophage-Dependent Cyst Expansion in Autosomal Dominant Polycystic Kidney Disease","volume":"29","author":"Cassini","year":"2018","journal-title":"J. Am. Soc. Nephrol"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1681\/ASN.2018010074","article-title":"Interactions between Macrophages and Cyst-Lining Epithelial Cells Promote Kidney Cyst Growth in Pkd1-Deficient Mice","volume":"29","author":"Yang","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1242\/dmm.003194","article-title":"The ADPKD genes pkd1a\/b and pkd2 regulate extracellular matrix formation","volume":"3","author":"Mangos","year":"2010","journal-title":"Dis. Models Mech."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1600-0773.1988.tb01895.x","article-title":"Rat kidney lysosomal membrane damage induced by suramin in vitro and in vivo","volume":"62","author":"Akanji","year":"1988","journal-title":"Pharmacol. Toxicol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"L709","DOI":"10.1152\/ajplung.00418.2012","article-title":"Always cleave up your mess: Targeting collagen degradation to treat tissue fibrosis","volume":"304","author":"McKleroy","year":"2013","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jnci\/85.8.611","article-title":"Suramin, an active drug for prostate cancer: Interim observations in a phase I trial","volume":"85","author":"Eisenberger","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/1097-0142(19940901)74:5<1612::AID-CNCR2820740519>3.0.CO;2-Q","article-title":"Acute renal toxicity associated with suramin in the treatment of prostate cancer","volume":"74","author":"Figg","year":"1994","journal-title":"Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00003088-198815020-00001","article-title":"Clinical pharmacokinetics of anthelmintic drugs","volume":"15","author":"Edwards","year":"1988","journal-title":"Clin. Pharm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1073\/pnas.77.6.3700","article-title":"Experimental animal model for mucopolysaccharidosis: Suramin-induced glycosaminoglycan and sphingolipid accumulation in the rat","volume":"77","author":"Constantopoulos","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"100089","DOI":"10.1016\/j.jlr.2021.100089","article-title":"Inhibition of lysosomal phospholipase A2 predicts drug-induced phospholipidosis","volume":"62","author":"Treadwell","year":"2021","journal-title":"J. Lipid. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrneph.2014.137","article-title":"Translational research in ADPKD: Lessons from animal models","volume":"10","author":"Happe","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1681\/ASN.2015020132","article-title":"Food Restriction Ameliorates the Development of Polycystic Kidney Disease","volume":"27","author":"Warner","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.2011040340","article-title":"Dose-dependent effects of sirolimus on mTOR signaling and polycystic kidney disease","volume":"23","author":"Novalic","year":"2012","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/15\/8499\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:23Z","timestamp":1760140823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/15\/8499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,31]]},"references-count":54,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["ijms23158499"],"URL":"https:\/\/doi.org\/10.3390\/ijms23158499","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,31]]}}}